加载中
NASDAQHealthcareMedical - Healthcare Information Services
最新数据
US$0.4099
−US$0.0121 · -2.87%
Mangoceuticals, Inc. dedicates its operations to the creation, promotion, and distribution of a variety of health and wellness products and services specifically designed for men. These offerings are primarily delivered through a telemedicine platform. The company's product line includes treatments for erectile dysfunction, marketed under the 'Mango' brand. Consumers can purchase these items directly from its official online portal, mangorx.com. Established in 2021, Mangoceuticals, Inc. is headquartered in Dallas, Texas, and operates as an affiliate of Cohen Enterprises, Inc.
常规交易时段
US$0.4099
−US$0.0121 · -2.87%
盘中时间采用ET。市场数据可能有所延迟。
Mangoceuticals, Inc. dedicates its operations to the creation, promotion, and distribution of a variety of health and wellness products and services specifically designed for men. These offerings are primarily delivered through a telemedicine platform. The company's product line includes treatments for erectile dysfunction, marketed under the 'Mango' brand. Consumers can purchase these items directly from its official online portal, mangorx.com. Established in 2021, Mangoceuticals, Inc. is headquartered in Dallas, Texas, and operates as an affiliate of Cohen Enterprises, Inc.
日内区间
当前US$0.4099
52周区间
当前US$0.4099
盘中时间采用ET。市场数据可能有所延迟。
GoAI 评分
卖出
估值
35
偏贵
情绪
51
多空交织
风险
83
极高风险
动量
23
动能减弱
完整 GoAI 研究
继续查看更深入的依据、催化因素和风险。
Mangoceuticals, Inc. dedicates its operations to the creation, promotion, and distribution of a variety of health and wellness products and services specifically designed for men. These offerings are primarily delivered through a telemedicine platform. The company's product line includes treatments for erectile dysfunction, marketed under the 'Mango' brand. Consumers can purchase these items directly from its official online portal, mangorx.com. Established in 2021, Mangoceuticals, Inc. is headquartered in Dallas, Texas, and operates as an affiliate of Cohen Enterprises, Inc.
日内区间
当前US$0.4099
52周区间
当前US$0.4099
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目（USD） | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 45.6万 USD | 61.59万 USD | 73.15万 USD | 8939 USD | — |
| 销货成本 | 20.56万 USD | 23.59万 USD | 30万 USD | 4089 USD | — |
| 毛利 | 25.04万 USD | 38万 USD | 43.15万 USD | 4850 USD | — |
| 销售、一般及管理费用 | 1672.15万 USD | 789.82万 USD | 541.69万 USD | 199.64万 USD | 1.75万 USD |
| 营业费用 | 1940.54万 USD | 835.2万 USD | 965.04万 USD | 199.64万 USD | 1.75万 USD |
| 利息收入 | — | — | 6473 USD | — | — |
| 利息支出 | 10.35万 USD | 1.37万 USD | — | 6473 USD | 181 USD |
| 折旧和摊销 | 172.42万 USD | 73.15万 USD | 2.49万 USD | 3863 USD | — |
| 营业利润 | −1915.5万 USD | −797.2万 USD | −921.89万 USD | −199.16万 USD | −1.75万 USD |
| 净利润 | −2064.35万 USD | −870.6万 USD | −921.24万 USD | −199.81万 USD | −1.77万 USD |
公司数据更新于 2026年10月12日。
近期已公布业绩
近期已公布业绩
| 行动 | 生效日期 | 详情 | 记录日期 | 付款日期 |
|---|---|---|---|---|
股票拆分 | 2024年10月16日 | 1:15 | — | — |
已生效 2024年10月16日
1:15
报告持有此股票敞口的交易所交易基金。
AI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
